Bonny Johnson - Concepedia

Author

Bonny Johnson

Vion Pharmaceuticals (United States)

Also Known As

Bonny Johnson, Bonny L. Johnson

Publications

Citations

H-Index

Concepts

All Affiliations

Vion Pharmaceuticals (United States)Sidney Kimmel Comprehensive Cancer Center University of Maryland, Baltimore National Cancer Institute

About

Bonny Johnson is an author at Vion Pharmaceuticals (United States) specializing in medicine, oncology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	832
2	Pharmacology	4	4	315
3	Biomedical Engineering	1	1	298
4	Obstetrics	1	1	57
5	Pathology	1	1	219

Bonny Johnson

Publications

Citations

H-Index

Page 1

	Year	Citations
Transdermal delivery of desmopressin using a coated microneedle array patch system Michel Cormier, Bonny Johnson, Mahmoud Ameri, Journal of Controlled Release Transdermal DeliveryTopical DrugWound HealingBiomedical EngineeringDermatology	2004	298
Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy Richard I. Fisher, Vincent T. DeVita, Bonny Johnson, The American Journal of Medicine Prognostic FactorsLymphoid NeoplasiaHematological MalignancyCombination ChemotherapyMedicine	1977	219
Transdermal Delivery of Antisense Oligonucleotides with Microprojection Patch (macroflux®) Technology WeiQi Lin, Michel Cormier, Ahmad Samiee, Pharmaceutical Research	2001	188
A Phase I study of the novel ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) in combination with the nucleoside analog fludarabine for patients with refractory acute leukemias and aggressive myeloproliferative disorders Judith E. Karp, Francis J. Giles, Ivana Gojo, Leukemia Research Hematological MalignancyOncologyNucleoside Analog FludarabineMedicineAggressive Myeloproliferative Disorders	2007	98
A phase I trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone in combination with gemcitabine for patients with advanced cancer Yun Yen, Kim Margolin, James H. Doroshow, Cancer Chemotherapy and Pharmacology Medicinal ChemistryAdvanced Cancer3-Aminopyridine-2-carboxaldehyde ThiosemicarbazoneMedicinePharmacology	2004	87
Phase I and pharmacokinetic study of Triapine®, a potent ribonucleotide reductase inhibitor, in adults with advanced hematologic malignancies Ivana Gojo, Michael L. Tidwell, Jacqueline M. Greer, Leukemia Research Advanced Hematologic MalignanciesMedicinePharmacologyPharmacokinetic StudyPharmacotherapy	2007	73
Hexamethylmelamine in alkylating agent-resistant ovarian carcinoma Bonny Johnson, Richard I. Fisher, Richard A. Bender, Cancer Attractive AgentChemoprevention StrategyAgent-resistant Ovarian CarcinomaMedicinePharmacology	1978	57

Page 1